Ftse Mib
38.819,62
0,78%
DAX
23.419,48
1,30%
S&P 500
5.738,52
-1,78%
NASDAQ
18.069,26
-2,61%
Bitcoin
89.259,39
-1,51%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Vivos Therapeutics Inc (VVOS) Vivos Therapeutics Inc (VVOS) Notizie

Vivos Therapeutics Inc

VVOS
3,54
0,08 (2,31%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:33:00
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/2/202514:30GLOBEVivos Therapeutics Expands Strategic Alliance in Colorado..
18/2/202514:30GLOBEVivos Therapeutics to Participate in Fireside Chat with..
14/2/202514:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
14/2/202513:55EDGAR2Form 8-K - Current report
11/2/202522:26EDGAR2Form S-3 - Registration statement under Securities Act of..
31/1/202523:00EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
31/1/202506:15EDGAR2Form EFFECT - Notice of Effectiveness
29/1/202512:04EDGAR2Form S-1/A - General form for registration of securities..
22/1/202512:09EDGAR2Form S-1 - General form for registration of securities under..
26/12/202413:06EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
23/12/202423:29EDGAR2Form 8-K - Current report
23/12/202414:00GLOBEVivos Therapeutics Announces $3.5 Million Registered Direct..
27/11/202423:25EDGAR2Form 8-K - Current report
27/11/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202422:20EDGAR2Form 8-K - Current report
14/11/202422:05EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
14/11/202422:05GLOBEVivos Therapeutics Reports Third Quarter 2024 Financial..
13/11/202423:00GLOBEVivos Therapeutics Schedules Release of Third Quarter 2024..
06/11/202422:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
08/10/202413:30GLOBEVivos Therapeutics Granted CPT® Coverage and Reimbursement..
24/9/202420:59EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
20/9/202414:05EDGAR2Form 8-K - Current report
20/9/202414:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
19/9/202413:00GLOBEVivos Therapeutics Announces Pricing of $4.3 Million..
18/9/202423:15APSHealthcare Shares Pop On FDA Clearance
18/9/202414:00EDGAR2Form 8-K - Current report
18/9/202413:00GLOBEVivos Therapeutics Receives Groundbreaking FDA 510(k)..
17/9/202422:05EDGAR2Form 8-K - Current report
12/9/202423:00EDGAR2Form 8-K - Current report
14/8/202422:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202422:05GLOBEVivos Therapeutics Reports Second Quarter 2024 Financial..
14/8/202413:30GLOBEVivos Therapeutics Schedules Release of Second Quarter..
08/8/202423:19EDGAR2Form 424B1 - Prospectus [Rule 424(b)(1)]
30/7/202412:17EDGAR2Form S-3 - Registration statement under Securities Act of..
10/7/202414:00EDGAR2Form 8-K - Current report
27/6/202413:30GLOBEVivos Therapeutics Announces Positive Results From 7-Month..
14/6/202422:15EDGAR2Form 8-K - Current report
12/6/202413:30GLOBEVivos Therapeutics Closes $7.5 Million At-The-Market Private..
20/5/202419:04GLOBEConsolidated Water Comments on ISS and Glass Lewis Reports..
17/5/202422:43EDGAR2Form 8-K - Current report
15/5/202420:54EDGAR2Form 8-K - Current report
14/5/202422:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202422:05GLOBEVivos Therapeutics Reports First Quarter 2024 Financial..
14/5/202413:30GLOBEVivos Therapeutics Schedules Release of First Quarter 2024..
09/4/202413:30GLOBEVivos Therapeutics’ Flagship CARE Oral Medical Devices..
28/3/202421:05GLOBEVivos Therapeutics Reports Fourth Quarter and Full Year 2023..
28/3/202412:30GLOBEVivos Therapeutics Schedules Release of Fourth Quarter and..
Apertura: 3,46 Min: 3,35 Max: 3,8117
Chiusura: 3,46

La tua Cronologia

NASDAQ
VVOS
Vivos Therapeutics
BIT
F12519
Vontobel Financial Produ...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci